Polymer‐based nanocarriers that respond to oxidative stress by scavenging ROS and inhibiting the NLRP3 inflammasome have been widely developed for treating conditions characterized by oxidative stress and inflammation, such as sepsis‐related ALI. Here, NLRP3 is linked to acute respiratory distress syndrome.